Back to results
US 7,989,210 B2Granted
IL1RL-1 as a cardiovascular disease marker and therapeutic target
AssigneeThe Brigham and Women's Hospital, Inc.
InventorRichard T. Lee
Life of this patent
Estimating the term…
Abstract
Methods for evaluating the likelihood that a subject will benefit from treatment with an agent for reducing the risk of a cardiovascular condition, by evaluating levels of Interleukin 1 Receptor-Like 1 (IL1RL-1) polypeptides in a sample comprising serum from the subject.
Claims9
A method for evaluating the likelihood that a subject will benefit from treatment with an agent for reducing the risk of a cardiovascular condition, the method comprising:
- determining a level of an Interleukin 1 Receptor-Like 1 (IL1RL-1) polypeptide in a sample comprising serum from the subject, and
- comparing the level of the IL1RL-1 polypeptide to a predetermined value, wherein the presence of a level of the IL1RL-1 polypeptide that is above the predetermined value indicates that the subject is likely to benefit from treatment with an agent for reducing the risk of a cardiovascular condition.
Dependencies are inferred from the claim text.